Researchers at Brigham and Women’s Hospital in Boston have released a study concluding that low levels of the hormone melatonin may play a role in developing type 2 diabetes, USA Today reports. They found that women with low levels of melatonin at night had twice the risk of developing type 2 diabetes as those with high levels.
America’s seen a skyrocketing rate of diabetes in recent years. Almost 26 million children ...
continue reading...
The Indian company Ranbaxy will resume production of its generic version of the anti-cholesterol drug Lipitor in the United States, according to a Reuters story.
The company had recalled the drug, called atorvastatin, in November after particles of glass were found in certain lots.
The original Lipitor, manufactured by Pfizer Inc., has also been the source of some safety concerns.
The U.S. Food and Drug Administration has added warnings to the labels of ...
continue reading...
A new study by Canadian researchers found that strong doses of the anti-cholesterol drugs called statins put patients at risk of potentially deadly kidney problems, The Daily Telegraph reports.
The researchers, from the Lady Davis Institute for Medical Research in Quebec, said that taking high doses of atorvastatin — better known by its brand name Lipitor — simvastatin or rosuvastatin increases the risk of being hospitalized with a condition called acute ...
continue reading...
A study linked the cholesterol drug Tredaptive to serious side effects that included development of diabetes, gastrointestinal problems, bleeding and infections, according to a Reuters report.
Manufacturer Merck had already decided not to sell the drug in the United States and to take it off the market in dozens of other countries, after findings that it failed to prevent heart attacks, strokes, death and other complications in heart patients.
Tredaptive isn’t ...
continue reading...
A recent study has put America’s health care and work-related costs related to diabetes at $245 billion in 2012, according to a story in USA Today. That represents a 41 percent increase from 2007, when the cost was $174 billion.
Diabetes, a disease in which blood glucose levels are above normal, is the country’s seventh leading cause of death, according to the U.S. Centers for Disease Control and Prevention.
The study, commissioned ...
continue reading...According to a story in the Huffington Post, federal officials are warning of an “alarming” increase in diabetes rates, projecting that as many as one in three U.S. adults could have the condition by 2050 if current trends continue.
The U.S. Centers for Disease Control and Prevention already estimate that one in 10 Americans – about 24 million people — now have diabetes. According to the new estimate, that number may rise to 76 million to 100 million in the coming ...
continue reading...
